ArticleCancer research2014
Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response.
Jiusheng Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
23 papers cite it
this papercites it
ArticleCancer research2014
Jiusheng Deng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.